Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 6 1
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 4 1
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1
Low Molecular Weight Heparin Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/07/2021 5 1
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/06/2021 8 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Breast milk Potential treatment - pre-clinical evidence Natural product Antiviral Dec/01/2020 2 0
(-)-beta-Sesquiphellandrene Potential treatment - theoretical effect Natural product Antiviral Nov/27/2020 1 0
SARS-CoV-2 RBD-Fc Potential treatment - pre-clinical evidence Experimental Vaccine Nov/27/2020 1 0